Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction. Curr Opin Cardiol. 2015 May; 30(3):250-8.
View in:
PubMed
subject areas
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Benzazepines
Cardiovascular Agents
Heart Failure
Humans
Mineralocorticoid Receptor Antagonists
Phosphodiesterase 5 Inhibitors
Renin-Angiotensin System
Spironolactone
Stroke Volume
Water-Electrolyte Imbalance